Emanuele Nicastri

Author PubWeight™ 57.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Seroprevalence of dengue infection: a cross-sectional survey in mainland Tanzania and on Pemba Island, Zanzibar. Int J Infect Dis 2011 1.78
2 Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions. Chest 2005 1.51
3 Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels. Clin Infect Dis 2014 1.47
4 Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infect Dis 2010 1.20
5 Leishmania infantum leishmaniasis in corticosteroid--treated patients. BMC Infect Dis 2006 1.19
6 Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses. Int J Infect Dis 2010 1.18
7 Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002 1.13
8 Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women. Curr HIV Res 2009 1.12
9 Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis 2010 1.05
10 Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy. AIDS 2005 1.04
11 Eosinophilic meningitis in a returned traveler from Santo Domingo: case report and review. J Travel Med 2007 1.02
12 Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. Int J Infect Dis 2009 0.98
13 Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation. J Med Virol 2009 0.98
14 Surgical site infections in Italian Hospitals: a prospective multicenter study. BMC Infect Dis 2008 0.98
15 Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety. AIDS 2010 0.93
16 Healthcare-associated infection in Italy: annual point-prevalence surveys, 2002-2004. Infect Control Hosp Epidemiol 2009 0.93
17 Nosocomial pulmonary infections in HIV-positive patients. Curr Opin Pulm Med 2005 0.92
18 Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 2003 0.91
19 Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. AIDS 2013 0.91
20 IgG against dengue virus in healthy blood donors, Zanzibar, Tanzania. Emerg Infect Dis 2014 0.91
21 Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. J Clin Microbiol 2003 0.90
22 Criteria for discharge of patients with Ebola virus diseases in high-income countries. Lancet Glob Health 2015 0.90
23 Prevalence trend and correlates of HHV-8 infection in HIV-infected patients. J Acquir Immune Defic Syndr 2002 0.90
24 Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis 2002 0.89
25 Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine. Malar J 2012 0.89
26 Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production. AIDS 2002 0.89
27 Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells. J Clin Microbiol 2002 0.87
28 Zika Virus Infection in the Central Nervous System and Female Genital Tract. Emerg Infect Dis 2016 0.86
29 Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report. J Med Case Rep 2008 0.84
30 SARS and the removal of personal protective equipment. CMAJ 2004 0.84
31 Impact of pre-therapy viral load on virological response to modern first-line HAART. Antivir Ther 2013 0.84
32 Strengthening tuberculosis diagnosis in a low-resource setting: experience learned in Dodoma, Tanzania. J Infect Dev Ctries 2013 0.84
33 A rare case of severe myopathy associated with etravirine use. AIDS 2010 0.84
34 Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA sequencing in a patient with leprosy: a case report. BMC Infect Dis 2013 0.84
35 KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection. J Med Virol 2011 0.82
36 Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC-UV. IUBMB Life 2009 0.82
37 Surgical site infections in plastic surgery: an italian multicenter study. J Surg Res 2007 0.82
38 Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy. J Clin Microbiol 2005 0.81
39 Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report. Clin Vaccine Immunol 2013 0.80
40 Viral hemorrhagic fevers: advancing the level of treatment. BMC Med 2012 0.80
41 Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART. AIDS Res Hum Retroviruses 2008 0.80
42 Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors. Int Immunopharmacol 2013 0.80
43 HIV-1 drug resistance in recently HIV-infected pregnant mother's naïve to antiretroviral therapy in Dodoma urban, Tanzania. BMC Infect Dis 2013 0.80
44 Molecular diagnosis and species identification of imported malaria in returning travellers in Italy. Diagn Microbiol Infect Dis 2011 0.79
45 Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens. J Med Virol 2007 0.78
46 HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. AIDS 2012 0.78
47 Therapeutic drug monitoring in the management of HIV-infected patients. Curr Med Chem 2008 0.78
48 Deep sequencing of plasma and proviral HIV-1 to establish coreceptor usage: what is the clinical impact of the quasispecies distribution? J Infect Dis 2011 0.78
49 Improvement of tuberculosis laboratory capacity on Pemba Island, Zanzibar: a health cooperation project. PLoS One 2012 0.78
50 Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis. Malar J 2011 0.78
51 Accuracy of indirect haemagglutination and western blot assays for the detection of anti-Schistosoma antibodies in non-severe febrile patients in two Tanzanian hospitals. Scand J Infect Dis 2012 0.77
52 Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. AIDS 2002 0.77
53 [Cases of Chikungunya fever in Italy in travellers returning from the Indian Ocean and risk of introduction of the disease to Italy]. Infez Med 2006 0.77
54 Clinical, Virologic, and Epidemiologic Characteristics of Dengue Outbreak, Dar es Salaam, Tanzania, 2014. Emerg Infect Dis 2016 0.76
55 Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections. Int J Infect Dis 2010 0.76
56 Consensus document on controversial issues in the diagnosis and treatment of bloodstream infections and endocarditis. Int J Infect Dis 2010 0.76
57 Stavudine protective function and emergence of Lamivudine resistance. Antimicrob Agents Chemother 2003 0.75
58 Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report. Infect Agent Cancer 2012 0.75
59 Initial treatment of HIV-1 infection. N Engl J Med 2008 0.75
60 Evidence of airborne transmission of SARS. N Engl J Med 2004 0.75
61 Human immunodeficiency virus polymorphisms and zidovudine resistance. Antimicrob Agents Chemother 2003 0.75
62 A waterborn zoonotic helminthiase in an Italian diver: a case report of a cutaneous Sparganum infection and a review of European cases. Pathog Glob Health 2016 0.75
63 Stopping antiretroviral therapy: role for therapeutic drug monitoring. AIDS 2008 0.75
64 Reply to "Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides", by Barreiro et al. AIDS 2003 0.75
65 Eight days vs 15 days of antibiotics for ventilator-associated pneumonia. JAMA 2004 0.75
66 Consensus document on controversial issues for the treatment of hospital-associated pneumonia. Int J Infect Dis 2010 0.75
67 A nosocomial and occupational cluster of hepatitis A virus infection in a pediatric ward. Infect Control Hosp Epidemiol 2002 0.75
68 Molecular Characterization of Autochthonous Chikungunya Cluster in Latium Region, Italy. Emerg Infect Dis 2018 0.75
69 Sonographic assessment of facial HIV-related lypoatrophy. Dermatol Surg 2009 0.75
70 The legal proceeding on the use of genotypic assays for the detection of HIV antiretroviral resistance in Italy: background and rationale for a consensus conference to establish guidelines. Scand J Infect Dis Suppl 2003 0.75
71 Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir. Scand J Infect Dis 2010 0.75
72 A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italian Society of Clinical Microbiology, the Italian Society of Microbiology, and GISIG (Italian Study Group on Severe Infections). Int J Infect Dis 2010 0.75
73 Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodology. Int J Infect Dis 2010 0.75